134 related articles for article (PubMed ID: 24969034)
1. Identification of differentially expressed genes and their subpathways in recurrent versus primary bone giant cell tumors.
Chen S; Li C; Wu B; Zhang C; Liu C; Lin X; Wu X; Sun L; Liu C; Chen B; Zhong Z; Xu L; Li E
Int J Oncol; 2014 Sep; 45(3):1133-42. PubMed ID: 24969034
[TBL] [Abstract][Full Text] [Related]
2. Differential gene expression in classic giant cell tumours of bone: Tenascin C as biological risk factor for local relapses and metastases.
Pazzaglia L; Conti A; Chiechi A; Novello C; Magagnoli G; Astolfi A; Pession A; Krenacs T; Alberghini M; Picci P; Benassi MS
Histopathology; 2010 Jul; 57(1):59-72. PubMed ID: 20653781
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical analyses of beta-catenin and cyclin D1 expression in giant cell tumor of bone (GCTB): a possible role of Wnt pathway in GCTB tumorigenesis.
Matsubayashi S; Nakashima M; Kumagai K; Egashira M; Naruke Y; Kondo H; Hayashi T; Shindo H
Pathol Res Pract; 2009; 205(9):626-33. PubMed ID: 19324500
[TBL] [Abstract][Full Text] [Related]
4. Transcriptomic and proteomic analyses in bone tumor cells: Deciphering parathyroid hormone-related protein regulation of the cell cycle and apoptosis.
Mak IW; Turcotte RE; Ghert M
J Bone Miner Res; 2012 Sep; 27(9):1976-91. PubMed ID: 22508574
[TBL] [Abstract][Full Text] [Related]
5. Expression of bone morphogenetic proteins in giant cell tumor of bone.
Kudo N; Ogose A; Ariizumi T; Kawashima H; Hotta T; Hatano H; Morita T; Nagata M; Siki Y; Kawai A; Hotta Y; Hoshino M; Endo N
Anticancer Res; 2009 Jun; 29(6):2219-25. PubMed ID: 19528484
[TBL] [Abstract][Full Text] [Related]
6. STAT1, IGF1, RAC1, and MDM2 Are Associated with Recurrence of Giant Cell Tumor of Bone.
Chen S; Du Z; Wu B; Shen H; Liu C; Qiu X; Zhang Y; Xu L; Li E; Zhong Z
J Immunol Res; 2018; 2018():4564328. PubMed ID: 29651441
[TBL] [Abstract][Full Text] [Related]
7. Parathyroid hormone-related protein (PTHrP) modulates adhesion, migration and invasion in bone tumor cells.
Mak IW; Turcotte RE; Ghert M
Bone; 2013 Jul; 55(1):198-207. PubMed ID: 23466453
[TBL] [Abstract][Full Text] [Related]
8. Giant cell tumors of the bone: molecular profiling and expression analysis of Ephrin A1 receptor, Claudin 7, CD52, FGFR3 and AMFR.
Guenther R; Krenn V; Morawietz L; Dankof A; Melcher I; Schaser KD; Kasper HU; Kuban RJ; Ungethüm U; Sers C
Pathol Res Pract; 2005; 201(10):649-63. PubMed ID: 16325507
[TBL] [Abstract][Full Text] [Related]
9. Gene expression profiling of giant cell tumor of bone reveals downregulation of extracellular matrix components decorin and lumican associated with lung metastasis.
Lieveld M; Bodson E; De Boeck G; Nouman B; Cleton-Jansen AM; Korsching E; Benassi MS; Picci P; Sys G; Poffyn B; Athanasou NA; Hogendoorn PC; Forsyth RG
Virchows Arch; 2014 Dec; 465(6):703-13. PubMed ID: 25304290
[TBL] [Abstract][Full Text] [Related]
10. Identification of markers of possible prognostic value in 57 giant cell tumors of bone.
Gamberi G; Serra M; Ragazzini P; Magagnoli G; Pazzaglia L; Ponticelli F; Ferrari C; Zanasi M; Bertoni F; Picci P; Benassi MS
Oncol Rep; 2003; 10(2):351-6. PubMed ID: 12579271
[TBL] [Abstract][Full Text] [Related]
11. Expression of osteoclast differentiation signals by stromal elements of giant cell tumors.
Atkins GJ; Haynes DR; Graves SE; Evdokiou A; Hay S; Bouralexis S; Findlay DM
J Bone Miner Res; 2000 Apr; 15(4):640-9. PubMed ID: 10780856
[TBL] [Abstract][Full Text] [Related]
12. TGF-β induced PAR-1 expression promotes tumor progression and osteoclast differentiation in giant cell tumor of bone.
Wang T; Jiao J; Zhang H; Zhou W; Li Z; Han S; Wang J; Yang X; Huang Q; Wu Z; Yan W; Xiao J
Int J Cancer; 2017 Oct; 141(8):1630-1642. PubMed ID: 28670703
[TBL] [Abstract][Full Text] [Related]
13. Expression and localization of extracellular matrix metalloproteinase inducer in giant cell tumor of bone.
Si AI; Huang L; Xu J; Kumta SM; Wood D; Zheng MH
J Cell Biochem; 2003 Aug; 89(6):1154-63. PubMed ID: 12898514
[TBL] [Abstract][Full Text] [Related]
14. Gene expression in giant-cell tumors.
Skubitz KM; Cheng EY; Clohisy DR; Thompson RC; Skubitz AP
J Lab Clin Med; 2004 Oct; 144(4):193-200. PubMed ID: 15514587
[TBL] [Abstract][Full Text] [Related]
15. Differential expression of filamin B splice variants in giant cell tumor cells.
Tsui JC; Lau CP; Cheung AC; Wong KC; Huang L; Tsui SK; Kumta SM
Oncol Rep; 2016 Dec; 36(6):3181-3187. PubMed ID: 27779699
[TBL] [Abstract][Full Text] [Related]
16. Expression of preosteoblast markers and Cbfa-1 and Osterix gene transcripts in stromal tumour cells of giant cell tumour of bone.
Huang L; Teng XY; Cheng YY; Lee KM; Kumta SM
Bone; 2004 Mar; 34(3):393-401. PubMed ID: 15003787
[TBL] [Abstract][Full Text] [Related]
17. Extraosseous primary and recurrent giant cell tumors: transforming growth factor-beta1 and -beta2 expression may explain metaplastic bone formation.
Teot LA; O'Keefe RJ; Rosier RN; O'Connell JX; Fox EJ; Hicks DG
Hum Pathol; 1996 Jul; 27(7):625-32. PubMed ID: 8698303
[TBL] [Abstract][Full Text] [Related]
18. Molecular analysis of primary and recurrent giant cell tumors of bone.
Rao UN; Goodman M; Chung WW; Swalski P; Pal R; Finkelstein S
Cancer Genet Cytogenet; 2005 Apr; 158(2):126-36. PubMed ID: 15796959
[TBL] [Abstract][Full Text] [Related]
19. Genomic instability in giant cell tumor of bone. A study of 52 cases using DNA ploidy, relocalization FISH, and array-CGH analysis.
Moskovszky L; Szuhai K; Krenács T; Hogendoorn PC; Szendroi M; Benassi MS; Kopper L; Füle T; Sápi Z
Genes Chromosomes Cancer; 2009 Jun; 48(6):468-79. PubMed ID: 19242928
[TBL] [Abstract][Full Text] [Related]
20. Epidermal growth factor receptor signalling contributes to osteoblastic stromal cell proliferation, osteoclastogenesis and disease progression in giant cell tumour of bone.
Balla P; Moskovszky L; Sapi Z; Forsyth R; Knowles H; Athanasou NA; Szendroi M; Kopper L; Rajnai H; Pinter F; Petak I; Benassi MS; Picci P; Conti A; Krenacs T
Histopathology; 2011 Sep; 59(3):376-89. PubMed ID: 22034878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
